design. Alternatively, blood protein binding of NNEI and MN-18 could contribute to this delay. Our kinetic calculations didn't account for this factor because blood protein binding isn't characterised for these compounds. Comparison in the molecular structures of artificial cannabinoid receptor agonists with that of trans No other section I m